Log In
Print this Print this

HIRMAb-EPO fusion protein (AGT-115)

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Inc.
DescriptionHuman erythropoietin (EPO) re-engineered by fusion to the carboxyl terminus of the heavy chain of a chimeric mAb to the human insulin receptor
Molecular Target Insulin receptor (INSR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today